These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 10179010)

  • 1. Marketplace. Managed care plans try to cope as drug ads spur patient demand.
    Moskowitz DB
    Med Health; 1998 May; 52(20):suppl 1-2. PubMed ID: 10179010
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals: a closer look.
    Peters B
    Mich Health Hosp; 2000; 36(1):12-4. PubMed ID: 11184282
    [No Abstract]   [Full Text] [Related]  

  • 3. Escalating need for comparative analysis of drugs within a therapeutic class.
    Giaquinta D
    Manag Care Interface; 2003 Oct; 16(10):32-4. PubMed ID: 14606258
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription costs become harder to swallow. Providers and payers get a big dose of reality with explosive spending and patient demand for new drugs.
    Hensley S
    Mod Healthc; 1999 Aug; 29(34):30-4. PubMed ID: 10557476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

  • 7. Employers push to manage prescription drug costs.
    Frieden J
    Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
    [No Abstract]   [Full Text] [Related]  

  • 8. Study shows increases in drug costs may be justified by improvements in outcomes.
    Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
    [No Abstract]   [Full Text] [Related]  

  • 9. The promise and problems of limited access. A conversation with Michael J. Dillon, R.Ph.. Interview by Patrick Mullen.
    Dillon MJ
    Manag Care; 1998 Nov; 7(11):44, 47-8, 51-3. PubMed ID: 10187128
    [No Abstract]   [Full Text] [Related]  

  • 10. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
    Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
    [No Abstract]   [Full Text] [Related]  

  • 11. Defying the prescription. Forget forecasts--drug sales soar under managed care.
    Hensley S
    Mod Healthc; 1998 Apr; 28(15):42. PubMed ID: 10178321
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing drug costs: the perception of managed care pharmacy directors.
    Litton LM; Sisk FA; Akins ME
    Am J Manag Care; 2000 Jul; 6(7):805-14. PubMed ID: 11067377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managed care outlook. Managing chronic illness becomes more crucial.
    Manag Care; 2003 Apr; 12(4):50. PubMed ID: 12747030
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of pharmaceutical direct advertising: opportunities and obstructions.
    Pinto MB; Pinto JK; Barber JC
    Health Mark Q; 1998; 15(4):89-101. PubMed ID: 10185455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA considers effects of managed care marketplace on drug promotional practices.
    Wechsler J
    Formulary; 1995 Dec; 30(12):840-1. PubMed ID: 10153083
    [No Abstract]   [Full Text] [Related]  

  • 17. "Doc, I saw this great new drug on TV...".
    Lowes R
    Med Econ; 1999 Apr; 76(8):71-2, 75-6. PubMed ID: 10387833
    [No Abstract]   [Full Text] [Related]  

  • 18. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 19. Precipitating factors for pharmaceutical firms.
    McCarthy R
    State Health Care Am; 1997; ():39-43. PubMed ID: 10168083
    [No Abstract]   [Full Text] [Related]  

  • 20. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.